Question to the Department for Work and Pensions:

To ask the Secretary of State for Work and Pensions, if he will make it his policy to bring forward legislative proposals to amend the Control of Substances Hazardous to Health Regulations 2002 to ensure that hazardous medicinal products with reprotoxic effects are controlled to the same standard as carcinogens and mutagens.

The Health and Safety Executive (HSE) has no current plans to amend The Control of Substances Hazardous to Health Regulations 2002 (COSHH) (as amended). These regulations place duties on all employers to assess the risk and ensure that the exposure of their employees to substances hazardous to health is either prevented or, where this is not reasonably practicable, adequately controlled. This includes any hazardous substances within hazardous medicinal products.

COSHH requires employers to carry out their risk assessments to establish the hazards arising from work activities, including the products and processes being used, and for the employer to put measures in place to control those risks. The risk assessment must take into account the properties of the hazardous substance and how and when they can give rise to risks to health.

If exposure cannot be prevented, employers must implement an effective programme of management procedures and put in place and maintain suitable and sufficient control measures to mitigate against the risks to health posed by any such exposure.